Cellcor Therapies

Xcell Therapeutics is a South Korean biotechnology company specializing in the development and commercialization of chemically defined media (CDM) for the cell and gene therapy (CGT) industry. The company's proprietary platform, branded as Cellcor, provides animal-component-free media that ensures high safety, consistency, and productivity in the cultivation of mesenchymal stem cells (MSCs) and exosomes. By eliminating the risks associated with serum-derived components, Xcell Therapeutics enables standardized manufacturing for advanced regenerative medicines. In addition to its media business, the company is advancing an internal pipeline of cell therapies targeting indications such as atopic dermatitis and hair loss, while offering contract development and manufacturing services to global biopharmaceutical partners.